U.S. equity futures are trading higher Tuesday as the calendar turned from a record November, including the Dow Jones Industrial Average closing above 30,000 points for the first time, as progress in the development of coronavirus vaccines kept investors in a buying mood.
Continue Reading Below
The future “seems incredibly bright and bullish,” Stephen Innes of Axi said in a report.
Hours before the opening bell, the Dow Jones Industrials stood at 29,921 (+0.99%), up 292 points, while in early trading, the tech-heavy Nasdaq was up 108 points (+0.88%) at 12,385. The S&P was also up, standing at 3,656.75 points (+0.92%), up 33.50.
In Washington, U.S. Federal Reserve Chairman Jerome Powell said in a statement Monday economic prospects are “extraordinarily uncertain” after the pace of improvement moderated. He said a full recovery is unlikely until the public is confident the disease is under control.
Powell was due to appear Tuesday before the Senate Banking Committee with Treasury Secretary Steven Mnuchin. The panel oversees the $2 trillion aid package approved by Congress in March.
On Monday, the S&P 500 declined to 3,621.63. The Dow Jones Industrial Average lost 0.9% to 29,638.64. The Nasdaq composite slipped 0.1% to 12,198.74.
The slide followed reports showing the pandemic dragging down U.S. economic activity in the near future. But investors appear to be looking beyond that.
Investors are encouraged by the end of uncertainty about the outcome of the U.S. presidential election. They are reassured Washington will be under divided control, reducing the chances of big changes in taxes or regulation.
Markets also have been heartened by announcements from pharmaceutical companies of advances in vaccine development.
One developer, Moderna, said Monday it is ready to apply for emergency approval in the United States and Britain. Pfizer and German partner BioNTech are asking to begin vaccinations in the U.S. in December. British regulators also are assessing the Pfizer shot and another from AstraZeneca.
Meanwhile, Asian stocks rose Tuesday after Chinese manufacturing improved, South Korea reported stronger exports and Australia's central bank left its benchmark lending rate at a record low.
Markets in Shanghai, Tokyo, Hong Kong and Sydney advanced as investors looked ahead to U.S. Federal Reserve Chairman Jerome Powell’s appearance before legislators a day after he said the pace of recovery is moderating.
Wall Street’s benchmark S&P 500 index ended November up 10.8% for its biggest monthly gain since April.
The Shanghai Composite Index gained 1.3% to 3,434.37 after an index of Chinese manufacturing activity by a business magazine, Caixin, hit a decade high in November. A separate survey Monday by the government statistics agency showed activity at a three-year high.
The Nikkei 225 in Tokyo advanced 1.2% to 26,750.43.
The Hang Seng in Hong Kong added 0.9% to 26,590.04 after the Chinese territory on Monday announced the closure of government offices and restrictions on restaurants and other businesses to stop a new spike in coronavirus infections.
The Kospi in Seoul advanced 1.8% to 2,637.55 after South Korea reported exports rose 4% in November over a year earlier, rebounding from October's decline. That was led by a 16.4% increase for semiconductor sales.
The S&P-ASX 200 in Sydney rose 1.1% to 6,588.50 after Australia’s central bank left its benchmark lending rate unchanged at 0.1%. The bank said an economic recovery is under way but is likely to be “uneven and drawn out.”
India's Sensex opened up 0.9% at 44,524.36. New Zealand declined while Southeast Asian markets rose.
In energy markets, benchmark U.S. crude oil lost 32 cents to $45.03 per barrel in electronic trading on the New York Mercantile Exchange. The contract fell 19 cents to $45.34 on Monday. Brent crude, used to price international oils, sank 32 cents to $47.56 per barrel in London. It dropped 59 cents from the previous session to $47.59.
The dollar edged up to 104.38 yen from Monday’s 104.34 yen. The euro advanced to $1.1960 from $1.1946.